Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 6, 2009, 12:28AM ET - U.S. Markets Closed. Dow Up 0.22% Nasdaq Up 0.98%
Biotransplant Inc. (BTRNQ.PK)On Nov 30: 0.0052   0.00 (0.00%)  
MORE ON BTRNQ.PK
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Biotransplant Inc.
Charlestown Navy Yard
Building 75 Third Avenue
Charlestown, MA 02129
United States - Map
Phone: 617-241-5200
Fax: 617-241-8780

DETAILS 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:105

BUSINESS SUMMARY 
BioTransplant Incorporated engages in the discovery, development, and commercialization of therapeutics, therapeutic devices, and therapeutic regimens designed to suppress undesired immune responses, and enhance the body’s ability to accept donor cells, tissues, and organs. Based on its ImmunoCognance™ approach, the company is developing a portfolio of products designed to treat a range of medical conditions, for which current therapies are inadequate. This ImmunoCognance™ technology is designed to overcome the serious side effects associated with organ transplantation or stem cell transplantation to treat cancer and other life threatening diseases. ImmunoCognance-based therapies are also expected to increase the therapeutic benefit of bone marrow transplants used to treat cancer patients.
Key Statistics

COMPANY WEBSITES 
No websites available for BTRNQ.PK
Search Yahoo! for:
More on Biotransplant Inc.


CORPORATE GOVERNANCE 
Biotransplant Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 28.5% of CGQ Universe companies and 12.7% of Pharmaceuticals, Biotechnology & Life Sciences companies.
Brought to you by Institutional Shareholder Services.

KEY EXECUTIVES 
No officers available for BTRNQ.PK


Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Profile for Another Symbol: Symbol Lookup
Annual ReportsSector Analysis